SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-16-001315
Filing Date
2016-07-12
Accepted
2016-07-12 16:11:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D - AMENDMENT NO. 2 FOR ARGOS THERAPEUTICS, INC. BY PHARMSTANDARD INT s13da_062916-argos.htm SC 13D/A 72265
  Complete submission text file 0000904454-16-001315.txt   73777
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88006 | Film No.: 161764092
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A